<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04917406</url>
  </required_header>
  <id_info>
    <org_study_id>US-Foot 3</org_study_id>
    <nct_id>NCT04917406</nct_id>
  </id_info>
  <brief_title>Effect of Iontophoresis vs. Ultrasound in Plantar Fasciitis&quot;. Plantar Fasciitis&quot;</brief_title>
  <official_title>Randomized Clinical Trial: Comparison in the Treatment of Plantar Fasciitis by Iontophoresis Versus Ultrasound.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Seville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Seville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Plantar fasciitis is inflammation of plantar fascia.The main symptom of plantar fasciitis&#xD;
      manifests itself as localized pain in the inner area of the foot and increases in intensity&#xD;
      after long periods of standing or resting. Its etiology is multifactorial and risk factors&#xD;
      include overweight, female gender, physical exercise (impact sports), biomechanical&#xD;
      imbalances of the foot and possible dysfunction of the functional twin-ankle-plantar&#xD;
      system.Generally speaking, conservative measures are recommended as initial treatment for&#xD;
      plantar fasciitis, and in situations where these are ineffective, corticosteroids are&#xD;
      sometimes administered. At the local level, the route of administration can be by&#xD;
      infiltration or iontophoresis.Iontophoresis consists of administering a drug through the skin&#xD;
      by applying an electric current locally. This technique can be considered as a safe and&#xD;
      effective method within the SLTF (Transcutaneous Drug Delivery Systems). It consists of&#xD;
      introducing ions through the skin by means of electricity using a direct current, with an&#xD;
      electrode carrying a positive charge (anode) and a negative charge (cathode). Its&#xD;
      administration is produced thanks to the repulsive force to carry the compound through the&#xD;
      skin by means of galvanic current.&#xD;
&#xD;
      This study aims to assess whether treatment with iontophoresis in subjects with plantar&#xD;
      fasciitis can show a more positive evolution in pain after a 6-week treatment period&#xD;
      (treatment frequency: 1 time per week) versus ultrasound (3 times per week) for 6 weeks.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fasciitis pain</measure>
    <time_frame>Baseline</time_frame>
    <description>Visual analog scale VAS to evaluate Heel pain intensity was referred to as 0-10, in which 0= no pain at all and 10= the worst pain possible</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health status</measure>
    <time_frame>Baseline</time_frame>
    <description>EQ-5D assesses health status in terms of five dimensions of health and is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition. EQ-5D can also be referred to as a patient-reported outcome (PRO) measure, because patients can complete the questionnaire themselves to provide information about their current health status and how this changes over time. 'EQ-5D' is not an abbreviation and is the correct term to use when referring to the instrument in general</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plantar fascia thickness in mm</measure>
    <time_frame>Baseline</time_frame>
    <description>The plantar fascia is assessed by ultrasound.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Improvement PGI-I questionnaire</measure>
    <time_frame>1 month</time_frame>
    <description>Patient (PGI-I). Patient Global Impression of Improvement.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Iontophoresis</condition>
  <condition>Ultrasound Therapy; Complications</condition>
  <condition>Fasciitis, Plantar</condition>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>Use of iontophoresis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lidocaine (local anesthetic) associated with dexamethasone (corticosteroid) will be administered by iontophoresis technique. Dose per session and iontophoresis: 10 minutes with an intensity of 4 mA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Use of ultrasound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The treatment for the control group will be applied with a frequency of 3 times a week as usually performed in the ACP of the University of Seville. The application dose will be 0.65 Watt for 7 minutes in the area of most painful affectation by means of a circular movement and 1MZ head.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Application of lidocaine together with dexamethasone</intervention_name>
    <description>Lidocaine 2% is applied on the positive pole while dexamethasone 4 mg/ml is applied on the negative pole. Through the use of current the drugs penetrate the fascia.</description>
    <arm_group_label>Use of iontophoresis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Application of ultrasound as physical therapy</intervention_name>
    <description>The application dose will be 0.65 Watt for 7 minutes in the area of most painful affectation by means of a circular movement and a 1MZ head.</description>
    <arm_group_label>Use of ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  plantar fasciitis&#xD;
&#xD;
          -  fascia thickness (greater or equal to 4mm).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  skin lesion&#xD;
&#xD;
          -  sensory neuropathy&#xD;
&#xD;
          -  current use of plantar supports&#xD;
&#xD;
          -  taking pharmacological treatment (15 days) or previous infiltrations (6 months)&#xD;
&#xD;
          -  previous surgery or fractures of the lower limb&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  allergy to the applied drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universidad de Sevilla</name>
      <address>
        <city>Sevilla</city>
        <zip>41008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurora Castro, Dra.677</last_name>
      <phone>677608957</phone>
      <email>auroracastro@us.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 1, 2021</study_first_submitted>
  <study_first_submitted_qc>June 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2021</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Seville</investigator_affiliation>
    <investigator_full_name>Aurora Castro Mendez</investigator_full_name>
    <investigator_title>Aurora Castro-MÃ©ndez</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

